Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
Open Access
- 22 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 28 (4), 649-660
- https://doi.org/10.1002/stem.324
Abstract
Tumor stem cells or cancer initiating cells (CICs) are single tumor cells that can regenerate a tumor or a metastasis. The identification and isolation of CICs remain challenging, and a variety of putative CIC markers have been described. We hypothesized that cell lines of the NCI60 panel contain CICs and express putative CIC markers. We investigated expression of putative CIC surface markers (CD15, CD24, CD44, CD133, CD166, CD326, PgP) and the activity of aldehyde dehydrogenase in the NCI60 panel singly and in combination by six-color fluorescence-activated cell sorting analysis. All investigated markers were expressed in cell lines of the NCI60 panel. Expression levels of individual markers varied widely across the 60 cell lines, and neither single marker expression nor simple combinations nor co-expression patterns correlated with the colony-formation capacity of cell lines. Rather, marker expression patterns correlated with tumor types in multidimensional analysis. Whereas some expression patterns correlated with tumor entities such as basal breast cancer, other expression patterns occurred across different tumor types and largely related to expression of a more mesenchymal phenotype in individual breast, lung, renal, and melanoma cell lines. Our data for the first time demonstrate that tumor cell lines display CIC markers in a complex pattern that relates to the tumor type. The complexity and tumor type specificity of marker display creates challenges for the application of cell sorting and other approaches to isolation of putative tumor stem cell populations and suggests that therapeutic targeting strategies will need to take this into account. STEM CELLS 2010;28:649–66028:649–660Keywords
Funding Information
- National Cancer Institute, National Institutes of Health (HHSN261200800001E)
- Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute
This publication has 41 references indexed in Scilit:
- Aldehyde dehydrogenase activity as a functional marker for lung cancerChemico-Biological Interactions, 2009
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cellsJournal of Molecular Medicine, 2008
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- The glycans of stem cellsCurrent Opinion in Chemical Biology, 2007
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Generation of a functional mammary gland from a single stem cellNature, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000